9 December 2022 - Pfizer and BioNTech today announced the companies have received fast track designation from the US FDA ...
16 May 2022 - The EUA authorises at home sample collection with testing performed in a laboratory. ...
3 February 2020 - Seqirus, a global leader in influenza prevention and pandemic response, today announced that the U.S. FDA ...
15 January 2020 - Novavax today announced that the U.S. FDA has granted fast track designation for NanoFlu, its recombinant quadrivalent ...
16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...
17 October 2018 - Seqirus today announced the U.S. FDA has approved Afluria Quadrivalent (influenza vaccine) for use in people ...
26 February 2018 - The current influenza season has been especially difficult, causing widespread illness that has affected all fifty ...
29 August 2016 - Seqirus is shipping trivalent and quadrivalent formulations of Afluria in the 2016-2017 influenza season. ...
24 May 2016 - CSL today announced that the US FDA has approved Seqirus’ Flucelvax Quadrivalent (Influenza Vaccine), the first four-strain, ...